A Florida company that was sued for violating the Kansas Consumer Protection Act for allegedly over-inflating the price of flu vaccine has agreed to settlement terms with the state, Attorney General Phill Kline announced last week.
Ft. Lauderdale, Fla.- based Meds-Stat was sued by Kline last month after an undercover investigation conducted by the Consumer Protection and Antitrust Division of his office revealed that the company solicited Kansas health agencies, hospitals, and pharmacies in an attempt to sell the flu vaccine at prices nearly 1,000 percent higher than they were two weeks earlier when a worldwide shortage of the vaccine was announced.
The swift legal action taken by the attorney general prevented the sale of any vaccine in the state at those prices.
Under the settlement, Meds-Stat has agreed to:
Affirm that they sold no vaccine in Kansas at the record prices;
Alter any future solicitations to comply with Kansas law;
Reimburse the state for the cost of the investigation, litigation, and other legal fees and
expenses, and;
Work with Attorney General Phill Klines Consumer Protection and Antitrust Division to identify problems inherent in the vaccine distribution network to prevent future instances of price gouging of pharmaceuticals.
Source: Kansas Attorney General
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.